mTORC1 activity in psoriatic lesions is mediated by aberrant regulation through the tuberous sclerosis complex (TSC)

被引：0
|
作者：
Ferreri, A. [1 ]
Lang, V. [1 ]
Diehl, S. [1 ]
Kaufmann, R. [1 ]
Buerger, C. [1 ]
机构：
[1] Goethe Univ, Dept Dermatol, Clin, Frankfurt, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2023年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P032 (OP05
引用
收藏
页码：E17 / E18
页数：2
相关论文
共 50 条
  • [1] mTORC1 activity in psoriatic lesions is mediated by aberrant regulation through the tuberous sclerosis complex (TSC)
    Lang, V.
    Ferreri, A.
    Diehl, S.
    Kaufmann, R.
    Buerger, C.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 (03) : E11 - E11
  • [2] mTORC1 Activity in Psoriatic Lesions Is Mediated by Aberrant Regulation through the Tuberous Sclerosis Complex
    Ferreri, Antonio
    Lang, Victoria
    Kaufmann, Roland
    Buerger, Claudia
    CELLS, 2022, 11 (18)
  • [3] Aberrant destabilization of the tuberous sclerosis complex (TSC) controls mTORC1 activity in psoriasis
    Lang, V.
    Ferreri, A.
    Diehl, S.
    Kaufmann, R.
    Buerger, C.
    EXPERIMENTAL DERMATOLOGY, 2022, 31 (02) : E16 - E16
  • [4] Differential IKK/NF-κB Activity Is Mediated by TSC2 through mTORC1 in PTEN-Null Prostate Cancer and Tuberous Sclerosis Complex Tumor Cells
    Gao, Yu
    Gartenhaus, Ronald B.
    Lapidus, Rena G.
    Hussain, Arif
    Zhang, Yanting
    Wang, Xinghuan
    Dan, Han C.
    MOLECULAR CANCER RESEARCH, 2015, 13 (12) : 1602 - 1614
  • [5] mTORC1 Paradoxically Drives MiT/TFE Activity and Lysosomal Biogenesis in Tuberous Sclerosis Complex
    Asrani, Kaushal
    Salles, Daniela
    Woo, Juhyung
    Vidotto, Thiago
    Murali, Sanjana
    Mendes, Adrianna
    Lotan, Tamara
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 535 - 535
  • [6] mTORC1 Paradoxically Drives MiT/TFE Activity and Lysosomal Biogenesis in Tuberous Sclerosis Complex
    Asrani, Kaushal
    Salles, Daniela
    Woo, Juhyung
    Vidotto, Thiago
    Murali, Sanjana
    Mendes, Adrianna
    Lotan, Tamara
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 535 - 535
  • [7] Tuberous sclerosis 1 (Tsc1) mediated mTORC1 activation promotes glycolysis in tubular epithelial cells in kidney fibrosis
    Cao, Hongdi
    Luo, Jing
    Zhang, Yu
    Mao, Xiaoming
    Wen, Ping
    Ding, Hao
    Xu, Jing
    Sun, Qi
    He, Weichun
    Dai, Chunsun
    Zen, Ke
    Zhou, Yang
    Yang, Junwei
    Jiang, Lei
    KIDNEY INTERNATIONAL, 2020, 98 (03) : 686 - 698
  • [8] TSC1 binding to lysosomal PIPs is required for TSC complex translocation and mTORC1 regulation
    Fitzian, Katharina
    Bruckner, Anne
    Brohee, Laura
    Zech, Reinhard
    Antoni, Claudia
    Kiontke, Stephan
    Gasper, Raphael
    Matos, Anna Livia Linard
    Beel, Stephanie
    Wilhelm, Sabine
    Gerke, Volker
    Ungermann, Christian
    Nellist, Mark
    Raunser, Stefan
    Demetriades, Constantinos
    Oeckinghaus, Andrea
    Kummel, Daniel
    MOLECULAR CELL, 2021, 81 (13) : 2705 - +
  • [9] Development of harmatomas is associated with constitutive activated mTORC1 in Tuberous Sclerosis complex
    Moeller, L. B.
    Schonewolf-Greulich, B.
    Rosengren, T.
    Larsen, L.
    Ostergaard, J.
    Sommerlund, M.
    Ostenfeldt, C.
    Stausbol-Gron, B.
    Linnet, K. Markussen
    Gregersen, P. Axel
    Jensen, U.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 621 - 621
  • [10] TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex
    Alesi, Nicola
    Khabibullin, Damir
    Rosenthal, Dean M.
    Akl, Elie W.
    Cory, Pieter M.
    Alchoueiry, Michel
    Salem, Samer
    Daou, Melissa
    Gibbons, William F.
    Chen, Jennifer A.
    Zhang, Long
    Filippakis, Harilaos
    Graciotti, Laura
    Miceli, Caterina
    Monfregola, Jlenia
    Vilardo, Claudia
    Morroni, Manrico
    Di Malta, Chiara
    Napolitano, Gennaro
    Ballabio, Andrea
    Henske, Elizabeth P.
    NATURE COMMUNICATIONS, 2024, 15 (01)
12345